Oral-Systemic Link: Page 44

Study: Esophageal cancer survival rates tied to race, income

By Donna Domino

Esophageal cancer patients who are black and in lower socioeconomic groups have higher mortality rates than white patients with higher incomes, according to a new study presented at the recent meeting of the Society of Thoracic Surgeons.

February 3, 2016

Athenex gets FDA OK for clinical trials of oral form of cancer drug

By DrBicuspid.com staff writers

Athenex has received U.S. Food and Drug Administration (FDA) allowance to proceed with clinical trials in patients of its oral form of the docetaxel anticancer drug, Oradoxel.

February 2, 2016

HELPTAG:PO_Vaccine_To_Help_Prevent_Oral_Cancer

February 1, 2016

NYU, UCLA get $2.4M grant to study cannabinoids for cancer pain

By DrBicuspid.com staff writers

The New York University (NYU) Bluestone Center for Clinical Research and the University of California, Los Angeles (UCLA) have received a five-year, $2.4 million grant from the National Cancer Institute to study the use of nonpsychotropic cannabinoids to suppress chronic cancer pain.

January 28, 2016

NCI cancer centers call for more HPV vaccinations

By DrBicuspid.com staff writers

All 69 of the National Cancer Institute (NCI)-designated cancer centers issued a statement calling for an increase in the number of HPV vaccinations.

January 26, 2016

DrBicuspid.com announces the 2015 Dental Excellence Award winners

By Tony Edwards

DrBicuspid.com is pleased to announce the winners of the 2015 Dental Excellence Awards. Awards will be handed out at the Chicago Dental Society Midwinter Meeting in February.

January 25, 2016

Global Oral Cancer forum to take place in March

By DrBicuspid.com staff writers

The inaugural Global Oral Cancer Forum will be held on March 4 and 5 at New York University in New York City.

January 24, 2016

U-M study finds natural dairy preservative kills cancer cells

By DrBicuspid.com staff writers

University of Michigan (U-M) researchers have found that nisin, a naturally occurring preservative that grows on dairy products, killed between 70% and 80% of head and neck cancer tumor cells in rodents after nine weeks and extended survival in a new study, according to a university release.

January 21, 2016

Study: Data suggest novel approach to treat early-stage oral cancer

By Tony Edwards

Of the many ongoing issues around oral cancer treatment is a lack of "significant improvement" in disease prognosis over the last several decades. Now a study in JAMA Otolaryngology -- Head and Neck Surgery presents, for the first time, outcome data for almost 250 patients using a novel optical approach at the point of care to treat early-stage oral cancer.

January 19, 2016

New study examines antibody's link to Sjogren's

By DrBicuspid.com staff writers

Upcoming research from the University at Buffalo will study the possible link between IgM, a supposedly protective type of antibody, to Sjögren's syndrome and other autoimmune diseases.

January 14, 2016

FDA fast-tracks Galera's oral mucositis therapy

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) has granted fast-track status to Galera Therapeutics for a drug that may reduce the severity and incidence of radiation- and chemotherapy-induced oral mucositis.

January 11, 2016

Study: Devices reduce blood pressure in sleep apnea patients

By Donna Domino

Both continuous positive airway pressure (CPAP) and mandibular advancement devices reduce blood pressure in patients with obstructive sleep apnea, according to a new study. There was no significant difference between the blood pressure outcomes with the two therapies, but CPAP had a considerably higher probability of reducing systolic pressure, the researchers found.

January 4, 2016

Previous Page

Page 44 of 151

Next Page